Quick Answer
Allarity Therapeutics, Inc. reported Total Assets of $18.26 million for fiscal year 2025.
Allarity Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $18.26M | -19.4% |
| 2024 | $22.65M | +90.9% |
| 2023 | $11.86M | -18.4% |
| 2022 | $14.54M | -70.7% |
| 2021 | $49.63M | +48.6% |
| 2020 | $33.40M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $20.80M | +2.1% | -1.9% |
| June 30, 2025 | $21.20M | -31.3% | -28.7% |
| March 31, 2025 | $29.73M | +148.4% | +31.3% |
| December 31, 2024 | $22.65M | +90.9% | +11.1% |
| September 30, 2024 | $20.38M | +46.9% | -34.0% |
| June 30, 2024 | $30.88M | +130.0% | +158.0% |
| March 31, 2024 | $11.97M | -5.8% | +0.9% |
| December 31, 2023 | $11.86M | -18.4% | -14.5% |
- Allarity Therapeutics, Inc. showed a decrease of -19.4% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Allarity Therapeutics, Inc.’s total assets has declined by 45.3% (from $33.40 million to $18.26 million).
- The most recent figure is from Allarity Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: